BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles Its 2021 Forecast Biotech Investing
Risankizumab Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease Biotech Investing
Naturally Splendid Announces Meridian 8-Store Chain To Carry NATERA Plant Based Foods Biotech Investing
HempFusion Wellness Inc. Completes USD$17,000,000 Initial Public Offering and Commences Trading on the Toronto Stock Exchange Biotech Investing
